Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 20, 2023 05:33 ET | Source: Transparency Market Research

Thyroid Function Test Market Size to Hit USD 2.6 billion by 2031, Expanding at a CAGR of 5.4% - Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global thyroid function test market is projected to flourish at a CAGR of 5.4% from...
March 18, 2021 08:30 ET | Source: Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference

CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
May 22, 2020 12:35 ET | Source: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger transaction...
May 06, 2020 09:15 ET | Source: Ritter Pharmaceuticals, Inc.

Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals

LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc....
April 16, 2020 14:07 ET | Source: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC

Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders to Vote on Proposed Merger Scheduled for May 14, 2020 LOS ANGELES , April 16, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc....